FAZIOLI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 2.482
EU - Europa 1.286
AS - Asia 504
AF - Africa 90
SA - Sud America 24
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 4.395
Nazione #
US - Stati Uniti d'America 2.453
IT - Italia 283
UA - Ucraina 257
SE - Svezia 192
SG - Singapore 152
IE - Irlanda 144
DE - Germania 133
CN - Cina 106
DK - Danimarca 100
HK - Hong Kong 86
CI - Costa d'Avorio 81
TR - Turchia 81
FI - Finlandia 61
KR - Corea 53
GB - Regno Unito 47
FR - Francia 39
CA - Canada 29
BR - Brasile 19
BE - Belgio 17
IN - India 8
JP - Giappone 6
MA - Marocco 5
AT - Austria 3
CO - Colombia 3
EU - Europa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
DZ - Algeria 2
NL - Olanda 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MC - Monaco 1
MY - Malesia 1
NG - Nigeria 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
VN - Vietnam 1
Totale 4.395
Città #
Chandler 351
Des Moines 268
Jacksonville 262
Boardman 158
Fairfield 156
Dublin 144
Ashburn 122
Ann Arbor 119
New York 99
Wilmington 86
Woodbridge 84
Hong Kong 82
Abidjan 81
Houston 81
Singapore 64
Lawrence 58
Princeton 58
Seattle 58
San Mateo 57
Cambridge 53
Centro 33
Milan 32
Marche 31
Ottawa 28
Turin 24
Redmond 20
Brussels 17
San Diego 17
Beijing 14
Los Angeles 13
Ancona 12
Helsinki 11
Rome 11
Washington 11
Guangzhou 10
Norwalk 7
Wuhan 7
Dallas 6
London 6
Padova 6
Shanghai 6
Tolentino 5
Auburn Hills 4
Frederico Westphalen 4
Jiaxing 4
Napoli 4
Porto 4
Roccella Jonica 4
Venice 4
West Jordan 4
Acton 3
Coimbatore 3
Genoa 3
Lecco 3
Nuremberg 3
Redwood City 3
Seoul 3
Tokyo 3
Venegono Superiore 3
Vienna 3
Wuxi 3
Algiers 2
Ascoli Piceno 2
Auckland 2
Bogotá 2
Dalian 2
Falls Church 2
Islington 2
Kyoto 2
Maiolati Spontini 2
Nanjing 2
Pavia 2
Pesaro 2
Quanzhou 2
Randers 2
Shenzhen 2
São Paulo 2
Tappahannock 2
Trieste 2
Urbino 2
Viborg 2
Virginia Beach 2
Alameda 1
Albuquerque 1
Almaty 1
Almirante Brown 1
Baku 1
Barranquilla 1
Belfast 1
Belgrade 1
Belo Horizonte 1
Bishkek 1
Boydton 1
Brasília 1
Budapest 1
Buffalo 1
Caserta 1
Chernihiv 1
Civitanova Marche 1
Copenhagen 1
Totale 2.893
Nome #
110 SERUM LEVELS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR IN PATIENTS WITH PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA 189
Fisiopatologia degli organi emopoietici e del sangue 131
In Vitro H2O2 Stress And Patterns Of Mitochondrial Damage In The Nctc 2544 Continuous Cell Line 130
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 112
Analysis of M1 and M2 tumor associated macrophages in tongue squamous cell carcinomas. 112
Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. 106
Biosynthesis and apical localization of the urokinase receptor in polarized MDCK epithelial cells. 101
The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. 98
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes. 98
Activation of transcription factors STAT1 and STAT5 in the mouse median eminence after systemic ciliary neurotrophic factor administration 98
Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase. 93
Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer's Disease 93
The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transduction. 92
Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. 91
Circulating inflamma-miRs in aging and age-related diseases. 89
erbB-2 autophosphorylation is required for mitogenic action and high-affinity substrate coupling. 87
The Experimental Pathology at Ancona: 50 Years of Exciting and Pioneering Research on Human Pathology 87
Plasma levels of interleukin-38 in healthy aging and in type 2 diabetes 85
Cytotoxic and genotoxic potential of asbestos fibers from environmental outcrops 85
Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity. 84
eps15, a novel tyrosine kinase substrate, exhibits transforming activity. 83
A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. 83
Absence of somatic mutations in natriuretic peptide receptor type A gene in human aldosterone-secreting adenomas 83
Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. 82
Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. 80
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemia. 79
A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. 78
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 78
77 Soluble urokinase receptor expression in urine is a prognostic marker in patients with transitional cell carcinoma of the bladder 77
Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent. 71
Analisys of Y-linked microdeletions in idiopathic oligo- and azoospermic patients 71
Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia. 71
Activation of alpha-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase 67
Cancerogenesi chimica e fisica 66
Polynucleotide and substrate for the epidermal growth factor receptor kinase (EPS8) 65
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 65
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 64
uPAR mimicking peptides 63
DNA encoding human and murine EPS15, a substrate for the epidermal growth factor receptor 62
A ligand-inducible anaplastic lymphoma kinase chimera is endocytosis impaired 62
Prognostic Relevance of Macrophage Phenotypes in High-grade Oral Tongue Squamous Cell Carcinomas 61
A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells 59
Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study. 58
SERUM SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS A USEFUL MARKER OF PROSTATE CANCER 55
Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer 54
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 53
The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing. 51
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 50
In Vitro H202 stress and patterns of mitochondrial damage in the NCTC 2544 Continuous cell line- a morphological and morphometric study. 47
Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells 47
Asbestos induced toxicity: in vitro different effects of different fibres. 47
Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy? 44
PPARγ expression in normal human placenta, hydatidiform mole and choriocarcinoma 44
Purification of tyrosine phosphorylated proteins by immunoaffinity chromatography and direct cloning of their cDNAs from bacterial expression libraries 43
Cytotoxicity in vitro of two non-commercial samples of chrysotile and fibrous erionite 42
The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency. 42
Serum soluble urokinase-type plasminigen activator receptor (Supar) is a useful marker of prostate cancer 41
Sex/gender-related differences in inflammaging 40
Survivin detection in saliva samples from patient with oral squamous cell carcinoma 40
The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation. 34
Bridging the gap between toxicity and carcinogenicity of mineral fibres by connecting the fibre parameters to the key characteristics of carcinogens: a comprehensive model inspiring asbestos-induced cancer prevention strategies 5
Totale 4.468
Categoria #
all - tutte 21.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020226 0 0 0 0 0 0 66 9 60 9 8 74
2020/2021813 37 77 96 6 114 39 107 38 106 59 87 47
2021/2022447 24 94 2 21 10 29 18 36 33 40 52 88
2022/20231.179 77 109 80 98 83 357 2 63 217 6 61 26
2023/2024585 88 15 35 98 92 123 7 14 2 28 15 68
2024/2025504 163 86 68 8 42 24 113 0 0 0 0 0
Totale 4.468